Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”

Annals of Thoracic Surgery Short Reports · Elsevier

Аннотация

Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Ningbo Xiao, Jinliang Dong, Qiujing Wang

Читать у издателя →

Похожие статьи